🇪🇺 Huluc63 in European Union

EMA authorised Huluc63 on 11 May 2016

Marketing authorisation

EMA — authorised 11 May 2016

  • Marketing authorisation holder: Bristol-Myers Squibb
  • Status: approved

Huluc63 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Huluc63 approved in European Union?

Yes. EMA authorised it on 11 May 2016.

Who is the marketing authorisation holder for Huluc63 in European Union?

Bristol-Myers Squibb holds the EU marketing authorisation.